GO
Loading...

Enter multiple symbols separated by commas

Drug Retail

More

  • Walgreen profit rises 16% on record prescriptions Tuesday, 23 Dec 2014 | 9:23 AM ET
    A Walgreens store is shown in Homestead, Fla.

    U.S. drugstore chain operator Walgreen reported a 16 percent rise in quarterly profit, helped by a record number of prescriptions filled.

  • Dec 23- U.S. drugstore chain operator Walgreen Co reported a better-than-expected quarterly profit, helped by a record number of prescriptions filled, sending its shares up 3.6 percent. The combined cost savings for Walgreen and Alliance Boots in the quarter were about $140 million. Net income attributable to Walgreen rose 16 percent to $809 million, or 85...

  • Walgreen profit rises 16 pct on record prescriptions Tuesday, 23 Dec 2014 | 7:42 AM ET

    Dec 23- U.S. drugstore chain operator Walgreen Co reported a 16 percent rise in quarterly profit, helped by a record number of prescriptions filled. Net income attributable to the company rose to $809 million, or 85 cents per share, in the first quarter ended Nov. 30, from $695 million, or 72 cents per share, a year earlier. Walgreen's shares were up 2 percent at $76 in...

  • Lottery ticket sector of 2015   Monday, 22 Dec 2014 | 12:46 PM ET
    Lottery ticket sector of 2015

    Mark Fisher, MBF Clearing Corp. chairman, shares his favorite stock in the biotech space.

  • Cramer's view of AbbVie-Express Scripts deal   Monday, 22 Dec 2014 | 8:52 AM ET
    Cramer's view of AbbVie-Express Scripts deal

    Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell.

  • Hepatitis C virus

    Express Scripts Medical Chief Steve Miller, provides insight to his company's deal with AbbVie. The two companies have come to a deal which gives Express Scripts a significant discount on the hepatitis C drug.

  • Express Scripts gets deal for AbbVie's hepatitis C drug

    CNBC's Meg Tirrell provides insight to a newly approved hepatitis C drug from AbbVie, which Express Scripts made an exclusive deal for a significant discount on the drug.

  • Dec 18- Rite Aid Corp, the third largest U.S. drugstore chain, raised its full-year earnings forecast after cutting it twice this year as higher sales of prescription drugs pushed up its profit and revenue in the third quarter. Rite Aid's shares jumped 13.3 percent to $6.87 in heavy premarket trading. Rite Aid, which sells over-the-counter drugs, personal care...

  • Rite Aid's quarterly profit jumps 46.5 pct Thursday, 18 Dec 2014 | 7:20 AM ET

    Dec 18- U.S. drugstore chain Rite Aid Corp's quarterly profit jumped 46.5 percent as higher sales of prescription drugs boosted same-store sales. The company's net income rose to $104.9 million, or 10 cents per share, in the third quarter ended Nov. 29 from $71.6 million, or 4 cents per share, a year earlier. Total revenue rose 5.3 percent to $6.69 billion.

  • Dec 10- Walgreen Co said Chief Executive Greg Wasson would retire and hand the reins on an interim basis to the head of Alliance Boots Holdings Ltd, a move that follows a series of events that has tested investor confidence in the U.S. drugstore chain. Walgreen said Wasson would step down shortly after it completes the purchase of the 55 percent it does not already...

  • Dec 10- U.S. drugstore chain operator Walgreen Co said Chief Executive Greg Wasson would retire after the completion of the company's pending merger with Alliance Boots Holdings Ltd.. Walgreen shares were up 2.3 percent in extended trading. Stefano Pessina, executive chairman of Alliance Boots, would serve as acting CEO, Walgreen said.

  • Walgreen CEO to retire after Alliance Boots' merger Wednesday, 10 Dec 2014 | 5:06 PM ET

    Dec 10- U.S. drugstore chain operator Walgreen Co said Chief Executive Greg Wasson would retire after the completion of its pending merger with Alliance Boots Holdings Ltd.. Walgreen shares were up 2.1 percent in extended trading. Stefano Pessina, executive chairman of Alliance Boots, would serve as acting CEO, Walgreen said.

  • Intercept CEO: NASH epidemic of liver disease   Friday, 14 Nov 2014 | 3:16 PM ET
    Intercept CEO: NASH epidemic of liver disease

    Intercept Pharmaceuticals CEO Mark Pruzanski, provides insight to his company's efforts to tackle NASH, or nonalcoholic steatohepatitis, saying over 10 percent of the U.S. population is thought to have NASH. Pruzanski also weighs in on being a public company.

  • Lots of risk in biotech: Pro   Monday, 10 Nov 2014 | 2:22 PM ET
    Lots of risk in biotech: Pro

    Discussing warning signs from Dendreon, and other worrisome companies, with Les Funtleyder, E Square Asset Management.

  • Dendreon declares bankruptcy   Monday, 10 Nov 2014 | 2:18 PM ET
    Dendreon declares bankruptcy

    Joseph Pantginis, Roth Capital, has been negative on Dendreon for a long time, ahead of the drugmaker's bankruptcy protection filing.

  • Supermarket sweep: What could lift Kroger shares Monday, 3 Nov 2014 | 12:37 PM ET
    A shopper outside a Kroger supermarket in Peoria, Illinois.

    Kroger has delivered 43 straight quarters of rising sales at stores open at least a year.

  • Drugmakers want indemnity   Thursday, 23 Oct 2014 | 1:38 PM ET
    Drugmakers want indemnity

    Drug companies may be looking for legal protection amid a massive demand for Ebola vaccines, reports CNBC's Meg Tirrell.

  • Former Walgreen CFO sues company for defamation Friday, 17 Oct 2014 | 7:59 AM ET

    Walgreen's former CFO sued the drugstore operator, alleging executives defamed him in news reports that blamed him for errors in its forecast.

  • GW Pharma: Focused on epilepsy   Tuesday, 14 Oct 2014 | 5:22 PM ET
    GW Pharma: Focused on epilepsy

    GW Pharma shares are down sharply after a study of its treatment for ulcerative colitis missed its primary endpoint in a mid-stage trial. GW Pharmaceuticals CEO Justin Gover, says the company's main focus is on its product for epilepsy.

  • Cannabis Expo: Pet food & more   Monday, 13 Oct 2014 | 8:57 AM ET
    Cannabis Expo: Pet food & more

    CNBC's Kate Rogers reports from the East Coast Cannabis Business Expo, on one pot entrepreneur taking CBD, which is an extract of the hemp plant, and putting it in pet food.